Abstract:Purpose: The purpose of this research was to evaluate the clinical significance of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen (PCNA) expression in tumor progression of cervical cancer.Design: Seventeen patients (40 samples) with consecutive cervical lesions from normal squamous epithelium, inflammation of the cervix to cervical intraepithelial neoplasm (CIN) and invasive cervical squamous cell cancer (SCC), or from CIN to SCC were collected for this study. Expression of p16INK4A, p14ARF, p53, and PCNA were detected by immunohistochemistry on paraffin-embedded sections. Human papillomavirus DNA was detected simultaneously with PCR and typed according to its DNA sequence.Results: p16INK4A overexpression was significantly higher in CIN (75%) and in SCC (75%) than in normal or inflammation of the cervix (12.5%; P < 0.01, P < 0.05, respectively). The positive rate of p14ARF expression was higher in SCC (83%) than in normal/inflammation of the cervix (25%; P < 0.05). PCNA expression was negative in normal or inflammation of the cervix, but an increased in expression was seen in 63.2% in CIN and 100% in SCC (P < 0.01, P < 0.05). When the time interval for disease progression from initial biopsy to CIN 3 or invasive cancer was compared with states of p16INK4A expression, cases stained positive for p16INK4A progressed within 64.2 months as compared with 122.3 months among those stained negatively (P < 0.01). Cases with increased p14ARF expression also had a short time interval for disease progression of 78.8 months as compared with 108.3 months in cases that were p14ARF negative. Cases with stable or decreased p53 expression had the shortest time interval for progression of 32.3 months in contrast to cases with no p53 expression (113.9 months). However, cases with increasing p53 expression progressed within 60.8 months.Conclusions: Our results suggested that altered states of p16INK4A, p14ARF, p53, and PCNA may be valuable markers to predict the progression of cervical neoplasia.

Radiotherapy changes expression of proliferating cell nuclear antigen in human cervical cancer

The relationship of the expression of proliferating cell nuclear antigen with pathobiological differentiation and radiosensitivity in cervical carcinoma

Expression of C-Fos Oncogene in Human Cervical Cancer Following Radiotherapy

Effects of p14ARF-MDM2-p53 Cell Cycle Regulation Pathway on the Carcinogenesis of Cervical Squamous Cell Carcinoma

Study on Expression of NMP238 and HSP70 in Cervical Carcinoma Tissues with Different Radiotherapy Sensitivity

Proliferative Activity in Cervical Intraepithelial Neoplasia and Cervical Carcinoma.

Proliferating Cell Nuclear Antigen Has an Association with Prognosis and Risks Factors of Cancer Patients: a Systematic Review

A Study on PCNA and Survivin as the Molecule Marks to Predict Tumor Radiosensitivity of Nasopharyngeal Carcinoma

Inhibition of EGFR Nuclear Translocation Attenuate Radioresistance Through Decreased P-Dna-pk Expression in Cervical Cancer Cells.

Gene Alterations After Ionizing Radiation In Human Cervical Carcinoma-Associated Endothelial Cells

The regulation effects on in vitro proliferation activities of human bladder cancer cells by stable antisense proliferating cell nuclear antigen gene transfer

The Predict Value of Proliferating Cell Nuclear Antigen on the Chemotherapeutical Sensitivity in Patients with Locally Advanced Cervical Cancer

The Inhibition Of Egfr Nuclear Translocation Attenuates Radioresistance Through Decreasing The Expression Of P-Dna-Pk In Cervical Cancer Cells

The Changes of Gene Express Profile of Nasopharyngeal Carcinoma Tissue Before and after the Radiotherapy of 2 Gy

Expression of HSP70 and Bcl2 Protein in Cervical Carcinoma Radiotherapy

Expression and significance of PTEN and PCNA in cervical squamous carcinoma tissue

Predictive Significance Of The Alterations Of P16ink4a, P14arf, P53, And Proliferating Cell Nuclear Antigen Expression In The Progression Of Cervical Cancer

EXPRESSION AND PROGNOSTIC EVALUATION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER

Low-Dose Radiation-Induced Epithelial-Mesenchymal Transition Through Nf-Kappa B In Cervical Cancer Cells

Relationship Between Expression of Proliferating Cell Nuclear Antigen and Prognosis of Colorectal Cancer

Relationship Between PCNA Expression and Apoptosis of Human Lung Cancer Cell Line